BST2 and pancreatic neoplasm: Notably, IHC analysis revealed that BST2 is highly expressed not only in cancer cells but also in nontumor stromal components, aligning with reports of BST2+ macrophages being associated with poor prognosis in pancreatic cancer [31] and BST2 expression in other cell types like stem cells [54].